Europe Human Papillomavirus (HPV) Vaccine Market Report: Industry Trends, Competitive Landscape, and Growth Projections 2022 to 2028

The Europe human papillomavirus (HPV) vaccine market is expected to grow from US$ 1,202.66 million in 2022 to US$ 1,598.81 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Human papillomavirus (HPV) is a common sexually transmitted infection and can cause cervical, oropharyngeal cancer, and cancer of the vagina, or anus. It also causes various diseases, such as anogenital warts and recurrent respiratory papillomatosis. HPVs have also been detected in lichen sclerosus, skin tags, seborrheic keratoses, epidermal cysts, actinic keratoses, and psoriatic plaques. A significant burden of HPV-associated diseases is driving the market. In women, cervical cancer is the fourth most common cancer. In addition, as per the report, titled "Human Papillomavirus and Related Diseases Report-Europe," in 2020, 8,449 women and 4,327 men had anal cancer in Europe. Such a high incidence rate of HPV-associated infections is favoring the market growth.

Get a Sample Copy of Report, Click Here:

https://www.businessmarketinsights.com/sample/BMIRE00026300?utm_source=OpenPr&utm_medium=10614

The Europe Human Papillomavirus (HPV) Vaccine market following are the manufacturers cover -

2A Pharma
ChengDu Institute of Biological Products Co., Ltd.
GlaxoSmithKline plc.
Inovio Pharmaceuticals
Merck & Co., Inc.
R-Pharm
Sanofi
Serum Institute of India Pvt. Ltd
Vaccitech
Walvax Biotechnology Co., Ltd.

The leading players of the Europe Human Papillomavirus (HPV) Vaccine industry, their market share, product portfolio, company profiles are covered during this report. Key market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Europe Human Papillomavirus (HPV) Vaccine players will help the industry aspirants in planning their strategies. The statistics presented in this report are an accurate and helpful guide to shaping your business growth.

Market Segment by Type, the product can be divided into:

The Europe human papillomavirus (HPV) vaccine market is segmented based on type, dosage, age, application, end user, and country. Based on type, the Europe human papillomavirus (HPV) vaccine market is segmented into 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. The quadrivalent HPV vaccine segment dominated the market in 2022. Based on dosage, the Europe human papillomavirus (HPV) vaccine market is bifurcated into 2 dose and 3 dose. The 2 dose segment dominated the market in 2022. Based on age, the Europe human papillomavirus (HPV) vaccine market is bifurcated into 9 to 14 years and 15 to 45 years. The 9 to 14 years segment dominated the market in 2022. Based on application, the Europe human papillomavirus (HPV) vaccine market is bifurcated into HPV-attributable cancer and genital warts. The HPV-attributable cancer segment dominated the market in 2022. Based on end user, the Europe human papillomavirus (HPV) vaccine market is segmented into doctors office, community health clinics, school-based health centers, health departments, hospitals, and others.

This analysis report also presents practical and practical case studies to help you get a clearer understanding of the subject. This analysis report has been prepared through industry analysis techniques and presented in a professional manner by including effective information graphics whenever necessary. It helps ensure business stability and rapid development to achieve notable remarks within the Europe Human Papillomavirus (HPV) Vaccine market.

Get Full Europe Human Papillomavirus (HPV) Vaccine Market Report :https://www.businessmarketinsights.com/reports/europe-human-papillomavirus-hpv-vaccine-market

Table of Contents: Europe Human Papillomavirus (HPV) Vaccine Market 2022 - 2028

Chapter 1: Overview of Europe Human Papillomavirus (HPV) Vaccine

Chapter 2: Regional Market Status and Forecast by Regions

Chapter 3: Regional Market Status and Forecast by Types

Chapter 4: Regional Market Status and Forecast by Downstream Industry

Chapter 5: Market driving correlational analysis

Chapter 6: Market competition status by major makers

Chapter 7: Major manufacturer's introduction and market data

Purchase a Copy of this Europe Human Papillomavirus (HPV) Vaccine Market 2022 - 2028 research report at:

https://www.businessmarketinsights.com/buy/single/BMIRE00026300?utm_source=OpenPr&utm_medium=10614

Chapter 8: Upstream and downstream market analysis

Chapter 9: Cost and gross margin analysis

Chapter 10: Marketing status analysis

Chapter 11: Market report conclusion

Chapter 12: Research methodology and reference

Note: This report may be customized to suit your requirements. Get in touch with our sales team so you can get a report tailored to your needs.

Contact Us:

If you have any questions about this report or would like further information, please contact us:

Contact person: Sameer Joshi

Email: sales@businessmarketinsights.com

Phone: +16467917070

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.